Assessment of artificial intelligence performance in answering questions on onabotulinum toxin and sacral neuromodulation.

Journal: Investigative and clinical urology

PMID: 40312898

Abstract

PURPOSE: This study aimed to evaluate the performance of three artificial intelligence (AI) models-ChatGPT, Gemini, and Copilot-in addressing clinically relevant questions about onabotulinum toxin and sacral neuromodulation (SNM) for the management of overactive bladder (OAB).

Authors

Ibrahim Hacibey

Department of Urology, Basaksehir Çam and Sakura City Hospital, Istanbul, Türkiye. drihacibey@gmail.com.
Ahmet Halis

Department of Urology, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Türkiye.

Keywords

Artificial Intelligence Botulinum Toxins, Type A Electric Stimulation Therapy Humans Neuromuscular Agents Surveys and Questionnaires Urinary Bladder, Overactive

External Resources

View on PubMed Access via DOI PubMed (40312898)

Assessment of artificial intelligence performance in answering questions on onabotulinum toxin and sacral neuromodulation.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals